Xenomics Pharmaceuticals Private Limited

Xenomics Pharmaceuticals Private Limited - trading in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U51909TG2021PTC148581 Incorporated 10 February 2021 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹49.71 Lakh
▲ 53% YoY
Net loss · FY 2024
₹19,571
Net margin -0.4%
EBITDA · FY 2024
₹1.62 Lakh
EBITDA margin 3.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
7
Provident fund records
Directors on board
2
As per MCA filings

About Xenomics Pharmaceuticals Private Limited

Data last updated:

Xenomics Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2021PTC148581.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shiva Raj Gandla (Managing Director) and Padma Gandla.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.

As per the financials filed for FY 2024, the company reported a revenue of ₹49.71 Lakh, a growth of 53% compared to the previous year. For the same year it recorded a net loss of ₹19,571 (net margin -0.4%) and EBITDA of ₹1.62 Lakh (EBITDA margin 3.3%).

The company has about 7 employees on its provident fund (EPFO) records.

Xenomics Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0017906).

Company details

CIN U51909TG2021PTC148581
Registration Number 148581
Incorporation Date 10 February 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0017906

Recognitions & Rankings of Xenomics Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0017906

Contact details

Xenomics Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009
  • Industry
    Trading, Specialty, Wholesale
Comprehensive company report
Xenomics Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Xenomics Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Xenomics Pharmaceuticals Private Limited, buy the company report.

Financials of Xenomics Pharmaceuticals Private Limited

FY 2024 filings available

Xenomics Pharmaceuticals Private Limited reported revenue of ₹49.71 Lakh (up 53% YoY) for FY 2024.

Revenue · FY 2024
₹49.71 Lakh ▲ 53%
Net loss · FY 2024
₹19,571 margin -0.4%
EBITDA · FY 2024
₹1.62 Lakh margin 3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 53%
EBITDA CAGR growth
1 year
▲ 119%

Revenue rose 53% in the latest year. EBITDA rose 119% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹19,571
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.3%
Net Profit Margin-0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Xenomics Pharmaceuticals Private Limited, buy the company report.

Board of directors of Xenomics Pharmaceuticals Private Limited

Xenomics Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shiva Raj GandlaManaging Director10 Feb 20215 Years 9 MonthsCurrent
Padma GandlaDirector10 Feb 20215 Years 9 MonthsCurrent

Peer comparison

Xenomics Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Unique Medicare Private Limited₹49.8 Lakh (FY 2025)127.0%New Delhi, Delhi, India
Oxygen Life Care Private Limited₹49.74 Lakh (FY 2024)-25.0%Howrah, West Bengal, India
Sunrise Mediworld Private Limited₹49.72 Lakh (FY 2025)36.0%Ahmedabad, Gujarat, India
Xenomics Pharmaceuticals Private Limitedthis company₹49.71 Lakh (FY 2024)-₹19,571-0.4%53.0%Hyderabad, Telangana, India
Laurel Healthcare Private Limited₹49.69 Lakh (FY 2025)-12.0%Dehradun, Uttarakhand, India
Vancorp Pharmaceuticals Private Limited₹49.64 Lakh (FY 2025)3.0%Gautam Budh Nagar, Uttar Pradesh, India
Reinheit Pharmaceuticals Private Limited₹49.48 Lakh (FY 2024)132.0%Kolkata, West Bengal, India

To see the full peer comparison of Xenomics Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Xenomics Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Xenomics Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Xenomics Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Padma Gandla was appointed as Director on 10 Feb 2021.

AGM
Xenomics Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Xenomics Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Padma Gandla was appointed as Director.
Appointed
Shiva Raj Gandla was appointed as Managing Director.
Incorporation
10 Feb 2021
Xenomics Pharmaceuticals Private Limited was registered on 10 Feb 2021 with Roc Hyderabad & aged 5 years 9 months as per MCA records.

Frequently asked questions

Xenomics Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 10 February 2021 (5+ years old) and is registered under CIN U51909TG2021PTC148581.

Xenomics Pharmaceuticals has 2 current directors:

The latest financial statements of Xenomics Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Xenomics Pharmaceuticals is U51909TG2021PTC148581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Xenomics Pharmaceuticals was incorporated on 10 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Xenomics Pharmaceuticals by revenue are Unique Medicare Private Limited, Oxygen Life Care Private Limited, Sunrise Mediworld Private Limited, Laurel Healthcare Private Limited, Vancorp Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Padma Gandla was appointed as Director on 10 Feb 2021. Shiva Raj Gandla was appointed as Managing Director on 10 Feb 2021.

Yes, Xenomics Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0017906).

The registered office of Xenomics Pharmaceuticals is at Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.

Xenomics Pharmaceuticals operates in the trading industry, in the specialty segment.

Xenomics Pharmaceuticals can be reached at its registered office: Syno.157 Flat No.105 Mansion Staff Road, Hyderabad, Telangana, India – 500009.